Sunday, February 25, 2024
Alexander Papp MD
People outside the mainstream medical establishment continue to show interest in the phenomenon of brain zaps, while academia remains unconcerned.
Recently a news site, in Australia of all places, ABC News, interviewed various researchers, including Dr Papp via email correspondence on the topic. The article was posted on January 28, 2024.
The article highlights the often overlooked and underreported challenges associated with withdrawing from antidepressant medications, as exemplified by the experiences of individuals like Maddy Britton. Maddy, a 26-year-old from Brisbane, encountered unexpected and frightening withdrawal symptoms when she stopped taking her prescribed antidepressant, escitalopram (Lexapro). Despite being on a low dose for two years, running out of her prescription without timely refills led to symptoms such as numbness in limbs and “brain zaps,” which she discovered through online communities.
Psychiatrist and academic Jon Jureidini from the University of Adelaide emphasizes that withdrawal problems related to antidepressants have been underestimated and underreported in research. He is conducting a survey to explore the adverse effects of withdrawal, including “brain zaps,” and suggests that the medical community has been slow to recognize and address this issue. Professor Jureidini is concerned that doctors may be overprescribing antidepressants without adequately warning patients about the difficulties of stopping them, emphasizing the importance of informed consent.
President of the Royal Australian College of General Practitioners, Nicole Higgins, acknowledges the increasing workload on general practitioners, with psychological issues becoming more prevalent among patients. While GPs aim to provide slow tapering plans to manage patients’ expectations during medication changes, the healthcare system is under strain, and there is concern about burnout and fragmentation of care. In the broader context, the article touches on the systemic challenges faced by GPs, who may resort to prescribing medications due to time constraints and insufficient training in mental health.
The article also discusses the limited research on “brain zaps,” with Alexander Papp from the University of California San Diego conducting some of the world’s first research into this phenomenon. Papp’s findings suggest an inverse relationship between the antidepressant’s half-life and the likelihood of causing brain zaps. He emphasizes the need for a scientific study to explore this phenomenon and highlights the lack of information and help available for those experiencing brain zaps during antidepressant withdrawal. The article concludes by echoing Maddy’s sentiment that the difficulty of getting off antidepressants needs greater attention and awareness.
And here is the link to it: Maddy felt ‘brain zaps’ after stopping antidepressants. No-one told her they were a common symptom of withdrawal
